Your browser doesn't support javascript.
loading
Evolution under low antibiotic concentrations: a risk for the selection of Pseudomonas aeruginosa multidrug-resistant mutants in nature.
Sanz-García, Fernando; Hernando-Amado, Sara; Martínez, José Luis.
Afiliação
  • Sanz-García F; Centro Nacional de Biotecnología, CSIC, Madrid, 28049, Spain.
  • Hernando-Amado S; Centro Nacional de Biotecnología, CSIC, Madrid, 28049, Spain.
  • Martínez JL; Centro Nacional de Biotecnología, CSIC, Madrid, 28049, Spain.
Environ Microbiol ; 24(3): 1279-1293, 2022 03.
Article em En | MEDLINE | ID: mdl-34666420
Antibiotic pollution of non-clinical environments might have a relevant impact on human health if resistant pathogens are selected. However, this potential risk is often overlooked, since drug concentrations in nature are usually below their minimal inhibitory concentrations (MICs). Albeit, antibiotic resistant bacteria can be selected even at sub-MIC concentrations, in a range known as the sub-MIC selective window. Using short-term evolution experiments, we have determined the sub-MIC selective windows of the opportunistic pathogen Pseudomonas aeruginosa for seven antibiotics of clinical relevance, finding the ones of quinolones to be the widest, and the ones of polymyxin B and imipenem, the narrowest. Clinically relevant multidrug-resistant mutants arose within the sub-MIC selective windows of most antibiotics tested, being some of these phenotypes mediated by efflux pumps' activity. The fact that the concentration of antibiotics reported in aquatic ecosystems - colonizable by P. aeruginosa - are, in occasions, higher than the ones that select multidrug-resistant mutants in our assays, has implications for understanding the role of different ecosystems and conditions in the emergence of antibiotic resistance from a One-Health perspective. Further, it reinforces the importance of procuring accurate information on the sub-MIC selective windows for drugs of clinical value in pathogens with environmental niches.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pseudomonas aeruginosa / Antibacterianos Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pseudomonas aeruginosa / Antibacterianos Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article